Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Appointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor
Appointment of Secretarial Auditor for Financial Year 2023-2024 Shelter Pharma Ltd - 543963 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Equity Issue For The Quarter Ended September 30, 2023
Statement of Deviation or variation in the use of proceeds of Equity Issue for the quarter ended September, 2023 Shelter Pharma Ltd - 543963 - Submission Of Standalone Unaudited Financial Results For The Half Year Ended On 30.09.2023 And Disclosure Pursuant To Regulation 33 Of SEBI (LODR) Regulations, 2015.
Submission of Half Yearly result as on 30th September, 2023 Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of Board Meeting Held Today On 10Th November, 2023
This is to inform you that, the Board of Directors at their meeting held on today i.e. 10th November, 2023 at 02:30 P.M. at Shelter Nagar, Nr. S. T. Bus Stand, Himmatnagar GJ 383001 IN, interalia considered and approved the following matter: 1. Approval of Standalone Unaudited Financial Result for the Half Year ended on 30th September, 2023 as per Regulation 33 of the SEBI (LODR) Regulations, 2015 along with Limited Review report; 2. Appointment of M/s. Murtuza Mandorwala & Associates, Practicing Company Secretary, as Secretarial Auditor of the Company for the Year 2023-24; 3. Appointment of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W, Ahmedabad , as Internal Auditors of the Company to conduct the Internal Audit for the financial year 2023-24. The Board Meeting started at 02:30 P.M. and ended on 03:15 P.M. Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 10Th November, 2023
Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Standalone Financial Result of the Company for the Half Year Ended on 30th September, 2023 as per Regulation 33 of the SEBI (LODR) Regulation, 2015; 2. Such Other agendas as may be considered necessary with the permission of the chair. Shelter Pharma Ltd - 543963 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of certificate under Reg 74(5) of SEBI (DP) Regulation 2018 for Quarter Ended 30th September, 2023 Shelter Pharma Ltd - 543963 - Closure of Trading Window
Intimation for Closure of Trading window for Half Year Ended 30th September 2023 Shelter Pharma Ltd - 543963 - Intimation With Regards To 'Shelter Pharma' Secured Order From Berlin International Medicines, Equipment & Devices Trading Co. W.L.L Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Company has secured a noteworthy order from Berlin International Medicines Equipment & Devise Trading Co. W.L.L for Product of D3 50ML and Ferrocure Capsule 3x10 Worth Ruppe''s 75 Lakh (Approximately) Shelter Pharma Ltd - 543963 - Announcement Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015.
Intimation of Approval Received for Export of Nutraceutical Products to Kuwait Market Shelter Pharma Ltd - 543963 - Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
Authorising KMP for determining the materiality of events or information and to intimate the Stock Exchange.